Expert Opinion on Investigational Drugs (@EO_InvDrugs) profile picture

MEDLINE-indexed international journal covering drugs in early stage clinical trials and their scope for future development. (2016 IF 4.03)

London, England
Joined July 2015
Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)Photo by Expert Opinion on Investigational Drugs (@EO_InvDrugs)
In light of the failure of Right to Try bill in The House, some background here: "Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits" https://teapawt.org/t.co/OZeGE9GXQV by @LiaTsimberidou et al from @MDAndersonNews #rightotry #openaccess
Expert Opinion on Investigational Drugs retweeted
Cefiderocol, a cephalosprin which targets siderophore uptake, suggested to have the potential to become first-line therapy for our most aggressive and lethal multidrug-resistant Gram-negative pathogens ncbi.nlm.nih.gov/pubmed/2931…
4
8
Paper on discontinued #Alzheimer's drugs is particularly relevant today: "Why are they failing? Is the treatment of symptomatic dementia too late? Are the therapeutic targets incorrect? Are the clinical methodologies imprecise, misleading, or inaccurate?" https://teapawt.org/t.co/d1OgWgUXwZ teapawt.org/bbchealth/status/95106…
Pharma giant pulls out of research into neuroscience bbc.in/2DfKtFK
1
2
Great to see @EnriqueSoto8 and @smlichtman_md's editorial "Considerations for clinical trial design in older adults with cancer" being featured in the #HemeAging session at last month's American Society of Hematology 2017 Annual Meeting #ASH17 #GeriOnc teapawt.org/Kristel_GT/status/9400…
Agree with @MelissaLoh21 .....@EnriqueSoto8's work being highlighted during the #hemeaging session #ash17 #siog #GeriOnc #youngsiog ncbi.nlm.nih.gov/m/pubmed/28… …
3
2
Expert Opinion on Investigational Drugs retweeted
BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations tandfonline.com/doi/full/10.…
1
2
Endoglin and ALK1 as therapeutic targets for hereditary hemorrhagic telangiectasia written by Ruiz-Llorente et al (@CIBERER) is Open Access and available here at Expert Opinion on Therapeutic Targets: https://teapawt.org/t.co/TO34zvkGu2
Interesting perspective on an emerging field - Investigational PD-1 inhibitors for advanced non-small lung cancer, new players in a shifting paradigm. Free to read editorial by Ghanem et al from @NorthwellHealth, available here: https://teapawt.org/t.co/YC8bqZvRuc
Editorial by @EnriqueSoto8 & @smlichtman_md - "Considerations for clinical trial design in older adults with cancer" is free to view online! teapawt.org/EnriqueSoto8/status/89…
3
3
BI 695502, US- & EU-approved Avastin showed 3-way bioequivalence with similar safety profile. Free access to trial - https://teapawt.org/t.co/dNXPYqoEPe
Expert Opinion on Investigational Drugs retweeted
SLEEP disturbances & severe STRESS as GLIAL activators: psychoneuroimmunology model explaining central sensitization ncbi.nlm.nih.gov/pubmed/2868…
Phase I trial assessing the bioequivalence of BI 695502, a bevacizumab biosimilar candidate. Free to access - https://teapawt.org/t.co/dNXPYqoEPe
Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 https://teapawt.org/t.co/K05V1hpAOb
Review - Preclinical to Phase II Amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease https://teapawt.org/t.co/FQGkuwjsGy
Review article - MERS-CoV spike protein: a key target for antivirals. Free to view until end of April. https://teapawt.org/t.co/3tk5EmVjiq
Read about accessory gene regulator-1 as a therapeutic target for C. difficile infection in this free editorial: https://teapawt.org/t.co/RXKigP2vTZ
Review article - Drugs in clinical development for the treatment of amyotrophic lateral sclerosis (ALS) https://teapawt.org/t.co/ztiYyTKrd0
Read about the latest investigational drugs for head and neck #cancer in this recently published #free #editorial https://teapawt.org/t.co/YANLP4lTuJ
An interesting new review recently published in Expert Opinion on Therapeutic Targets teapawt.org/ExpertOpinion/status/8…
This Post is from a suspended account. Learn more
Read this #free to view #editorial on KCC3 cotransporter as a therapeutic target for peripheral neuropathy... https://teapawt.org/t.co/hKQIZOdhOV
Phase 1 clinical trial data for biosimilar candidate BI695501 shows 3-way bioequivalence to US & EU approved Humira https://teapawt.org/t.co/ocbEHuwA3D